Sales and net income have dropped, although the growth in net income underperformed the average competitor within the industry, the revenue growth did not.
During the same period, stockholders' equity ("net worth") has remained virtually unchanged only decreasing by 3.51% from the same quarter last year.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY15||Q2 FY14|
|Net Sales ($mil)||3464.0||3533.0|
|Net Income ($mil)||494.0||499.0|
|Balance Sheet||Q2 FY15||Q2 FY14|
|Cash & Equiv. ($mil)||0.0||3867.0|
|Total Assets ($mil)||0.0||51440.0|
|Total Debt ($mil)||3300.0||3300.0|
|Profitability||Q2 FY15||Q2 FY14|
|Gross Profit Margin||0.0||20.95|
|Return on Assets||0.0||4.0|
|Return on Equity||12.69||12.47|
|Debt||Q2 FY15||Q2 FY14|
|Share Data||Q2 FY15||Q2 FY14|
|Shares outstanding (mil)||227.0||240.48|
|Div / share||0.57||0.5|
|Book value / share||70.12||68.6|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1900172.0||1198836.0|
BUY. This stock's P/E ratio indicates a discount compared to an average of 14.94 for the Insurance industry and a discount compared to the S&P 500 average of 21.25. Conducting a second comparison, its price-to-book ratio of 1.78 indicates a discount versus the S&P 500 average of 2.83 and a premium versus the industry average of 1.62. The price-to-sales ratio is above the S&P 500 average and well above the industry average, indicating a premium.
|CB 14.57||Peers 14.94||CB NA||Peers 11.58|
Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.
CB is trading at a valuation on par with its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|CB 16.01||Peers 14.26||CB NM||Peers 1.35|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
CB is trading at a premium to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
CB's negative PEG ratio makes this valuation measure meaningless.
|CB 1.78||Peers 1.62||CB 4.77||Peers 16.34|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CB is trading at a premium to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, CB is expected to significantly trail its peers on the basis of its earnings growth rate.
|CB 2.03||Peers 1.27||CB 0.38||Peers 10.33|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CB is trading at a significant premium to its industry.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
CB significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV